# Quality Assurance Report

## Identity

| Field | Value |
|---|---|
| QA Report ID | QA-PP-0156 |
| Population Package | PP-0156 |
| Title | Genetic Counseling for Hereditary Gastric Cancer |
| Version | 1.0.0 |
| Status | PASS |

---

# 1. Content QA

| Criterion | Result |
|---|---|
| Single clinical/educational question | PASS |
| Counseling-layer scope clearly defined | PASS |
| Pretest counseling included | PASS |
| Posttest counseling included | PASS |
| Informed consent included | PASS |
| Voluntary decision-making included | PASS |
| Benefits/limitations included | PASS |
| Possible results included | PASS |
| VUS distinction included | PASS |
| Negative-result uncertainty included | PASS |
| Psychosocial assessment included | PASS |
| Family implications included | PASS |
| Privacy/confidentiality included | PASS |
| Shared decision-making included | PASS |
| Multigene-panel counseling included | PASS |
| Vulnerable populations addressed | PASS |
| Downstream routing included | PASS |

---

# 2. Clinical QA

| Criterion | Result |
|---|---|
| Genetic counseling distinguished from genetic testing | PASS |
| Counseling distinguished from formal risk assessment | PASS |
| Pretest and posttest functions distinguished | PASS |
| Genetic testing not presented as mandatory | PASS |
| VUS not equated with pathogenic variant | PASS |
| Negative result not presented as absolute exclusion of hereditary risk | PASS |
| Family implications appropriately represented | PASS |
| Psychosocial dimensions appropriately represented | PASS |
| No unsupported gastric-specific counseling protocol created | PASS |
| No individual medical recommendation | PASS |
| No individual genetic-test recommendation | PASS |
| No individual variant interpretation | PASS |

---

# 3. Evidence QA

| Criterion | Result |
|---|---|
| NCI Cancer Genetics Risk Assessment and Counseling prioritized | PASS |
| NCI Genetics of Gastric Cancer used for gastric context | PASS |
| NCI HDGC PDQ used for disease-specific context | PASS |
| Evidence hierarchy defined | PASS |
| Evidence-to-content matrix completed | PASS |
| Evidence limitations explicitly stated | PASS |
| Source traceability included | PASS |
| No unsupported legal claims | PASS |
| No unsupported gastric-specific thresholds | PASS |

---

# 4. Educational QA

| Criterion | Result |
|---|---|
| Plain-language framing | PASS |
| Patient-centered explanation | PASS |
| Common misconceptions addressed | PASS |
| Uncertainty communicated | PASS |
| Autonomy preserved | PASS |
| No coercive language | PASS |
| Family implications understandable | PASS |
| VUS explanation understandable | PASS |
| Negative-result explanation appropriately cautious | PASS |

---

# 5. Governance QA

| Criterion | Result |
|---|---|
| CKO completed | PASS |
| Knowledge Passport completed | PASS |
| Primary Evidence Package completed | PASS |
| QA Report completed | PASS |
| Gold Specification v1.0 followed | PASS |
| Approved Decision Batch implemented | PASS |
| Scope not reopened after approval | PASS |
| Boundary/overlap explicitly defined | PASS |
| Knowledge Graph documented | PASS |
| Versioning complete | PASS |
| Four-artifact package complete | PASS |

---

# 6. Boundary / Overlap QA

## PP-0155

Owns:

> family history as gastric-cancer risk information.

PP-0156 begins after concern has been identified and focuses on counseling and informed decision-making.

**Result: PASS**

---

## PP-0154

Owns:

> formal hereditary gastric-cancer risk assessment.

PP-0156 uses the risk assessment as context but does not reproduce its assessment framework.

**Result: PASS**

---

## PP-0016

Owns:

> general genetic testing.

PP-0156 discusses testing only insofar as patients need to understand options, benefits, limitations and possible outcomes during counseling.

**Result: PASS**

---

## PP-0152

Owns:

> exact HDGC genetic-testing criteria.

PP-0156 does not reproduce the criteria.

**Result: PASS**

---

## PP-0150 / PP-0151

Own:

> CDH1 / CTNNA1-specific knowledge.

PP-0156 explains how results are discussed but does not interpret variants.

**Result: PASS**

---

## PP-0157

Owns:

> cascade testing.

PP-0156 covers family communication and explains why relatives may be affected, then delegates testing workflow.

**Result: PASS**

---

## PP-0158 / PP-0159

Own:

> risk-reducing surgery / endoscopic surveillance.

PP-0156 only explains that results may have downstream management implications.

**Result: PASS**

---

# 7. Clinical Safety QA

| Safety Item | Result |
|---|---|
| No diagnosis based on counseling content | PASS |
| No automatic genetic testing | PASS |
| No coercion to test | PASS |
| No individualized risk calculation | PASS |
| No individualized variant interpretation | PASS |
| No automatic surgery recommendation | PASS |
| No automatic surveillance recommendation | PASS |
| Legal/privacy information appropriately jurisdiction-limited | PASS |
| Family communication not converted into mandatory disclosure | PASS |
| Uncertainty preserved | PASS |

---

# 8. Knowledge Graph QA

The package is positioned correctly:

```text
PP-0155
Family history as risk information
        ↓
PP-0154
Hereditary risk assessment
        ↓
PP-0156
Genetic counseling
        ↓
Testing / result
        ↓
PP-0156
Posttest counseling
        ↓
┌───────────────┬───────────────┬─────────────────┐
▼               ▼               ▼
Gene result   Family result   Syndrome state
│               │               │
▼               ▼               ▼
PP-0150/51    PP-0157       PP-0149/153
                              │
                         PP-0158/159
```

No architecture conflict identified.

**Result: PASS**

---

# 9. Gold Artifact QA

| Artifact | Present | Status |
|---|---|---|
| 01_CKO.md | Yes | PASS |
| 02_KNOWLEDGE_PASSPORT.md | Yes | PASS |
| 03_PRIMARY_EVIDENCE_PACKAGE.md | Yes | PASS |
| 04_QA_REPORT.md | Yes | PASS |

---

# 10. Final QA Decision

# PASS

PP-0156 satisfies the locked Gold Population Package requirements.

The package establishes a distinct counseling layer:

> **PP-0156 = COUNSEL + SUPPORT INFORMED DECISION-MAKING**

It does not duplicate:

- PP-0154 risk assessment;
- PP-0016 testing;
- PP-0152 HDGC testing criteria;
- PP-0150/0151 gene interpretation;
- PP-0157 cascade testing;
- PP-0149/0153 syndrome states;
- PP-0158 surgery;
- PP-0159 surveillance.

---

# Mandatory Boundary

**Core =** genetic counseling purpose/process, pretest counseling, informed consent, testing options, benefits/limitations, possible results, posttest counseling, risk communication, psychosocial assessment, family implications, privacy/confidentiality, shared decision-making, uncertainty; **Supporting =** multigene-panel counseling, vulnerable populations, children/adolescents, tele-genetics/service models, reproductive/family-planning implications, jurisdiction-dependent insurance/employment issues; **Explicitly Excluded =** formal hereditary-risk assessment, exact HDGC criteria, laboratory/testing methodology, CDH1/CTNNA1 interpretation, ACMG/ClinGen variant classification, detailed cascade testing, HDGC-like management, surveillance, risk-reducing gastrectomy, syndrome-specific management, jurisdiction-specific legal advice; **Delegated-to PP =** PP-0154, PP-0016, PP-0152, PP-0149, PP-0150, PP-0151, PP-0153, PP-0157, PP-0158, PP-0159, Variant Interpretation, jurisdiction-specific legal/ethical resources.

---

# Final Status

**GOLD — PASS — READY FOR INTEGRATION**
